HomeCompareVINCW vs PM

VINCW vs PM: Dividend Comparison 2026

VINCW yields 124.22% · PM yields 3.48%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VINCW wins by $9.96M in total portfolio value
10 years
VINCW
VINCW
● Live price
124.22%
Share price
$1.61
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$10.01M
Annual income
$3,875,023.48
Full VINCW calculator →
PM
Philip Morris International
● Live price
3.48%
Share price
$165.34
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,492.02
Full PM calculator →

Portfolio growth — VINCW vs PM

📍 VINCW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVINCWPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VINCW + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VINCW pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VINCW
Annual income on $10K today (after 15% tax)
$10,559.01/yr
After 10yr DRIP, annual income (after tax)
$3,293,769.96/yr
PM
Annual income on $10K today (after 15% tax)
$296.12/yr
After 10yr DRIP, annual income (after tax)
$2,118.22/yr
At 15% tax rate, VINCW beats the other by $3,291,651.74/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VINCW + PM for your $10,000?

VINCW: 50%PM: 50%
100% PM50/50100% VINCW
Portfolio after 10yr
$5.03M
Annual income
$1,938,757.75/yr
Blended yield
38.54%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

VINCW
Analyst Ratings
1
Buy
Consensus: Buy
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.5% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VINCW buys
0
PM buys
0
No recent congressional trades found for VINCW or PM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVINCWPM
Forward yield124.22%3.48%
Annual dividend / share$2.00$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17.2%
Portfolio after 10y$10.01M$49.6K
Annual income after 10y$3,875,023.48$2,492.02
Total dividends collected$9.13M$11.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: VINCW vs PM ($10,000, DRIP)

YearVINCW PortfolioVINCW Income/yrPM PortfolioPM Income/yrGap
1← crossover$23,122$12,422.36$11,648$408.29+$11.5KVINCW
2$51,585$26,844.33$13,589$495.90+$38.0KVINCW
3$111,167$55,970.88$15,877$603.21+$95.3KVINCW
4$231,676$112,727.29$18,580$734.88+$213.1KVINCW
5$467,452$219,558.47$21,781$896.75+$445.7KVINCW
6$914,194$414,020.78$25,578$1,096.12+$888.6KVINCW
7$1,734,916$756,728.27$30,092$1,342.17+$1.70MVINCW
8$3,198,495$1,342,134.90$35,470$1,646.46+$3.16MVINCW
9$5,734,878$2,312,488.60$41,892$2,023.58+$5.69MVINCW
10$10,011,343$3,875,023.48$49,578$2,492.02+$9.96MVINCW

VINCW vs PM: Complete Analysis 2026

VINCWStock

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candidates include VIP217, an oral PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate to treat solid tumors; and VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is headquartered in Palo Alto, California.

Full VINCW Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this VINCW vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VINCW vs SCHDVINCW vs JEPIVINCW vs OVINCW vs KOVINCW vs MAINVINCW vs MOVINCW vs BTIVINCW vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.